Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, the discussions reveal a positive reception toward the statement, with posts like '@DrMauricioGon: Mas ciencia, menos drama' emphasizing a scientific approach over sensationalism, and others referencing the publication's details and significance. The tone varies from straightforward sharing to supportive commentary, reflecting a moderate level of engagement and recognition of the publication's influence on managing menopause symptoms.
Most discussions acknowledge the importance of the updated position statement, reflecting general support for the consensus and the value of recent research.
The posts show moderate interest, with some focusing on the significance of nonhormonal options and others simply referencing the publication.
Participants engage by sharing links, quoting the statement, and endorsing scientific approaches, indicating a meaningful level of involvement.
The discussions highlight the potential influence of the publication on clinical practice and awareness, suggesting a notable impact.
Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https://t.co/03h10TU7qk @MenopauseOrg @LippincottMed #menopause
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
This video reviews the 2023 position statement on nonhormonal treatments for menopause-related vasomotor symptoms, evaluating evidence for therapies such as cognitive-behavioral therapy, gabapentin, and fezolinetant…
This video reviews recent literature on nonhormonal treatments for menopause-related vasomotor symptoms, highlighting effective options such as cognitive-behavioral therapy, gabapentin, and fezolinetant, as recommended…
Heavy menstrual bleeding is a common issue among women of reproductive age, leading to iron deficiency and anemia that are often overlooked. These conditions significantly affect quality of life, cognitive functions…
Tratamientos no hormonales de los síntomas vasomotores de la menopausia 1. pmc.ncbi.nlm.nih.gov/articles/PMC... 2. pubmed.ncbi.nlm.nih.gov/37252752/
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
RT @DrMauricioGon: Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisor…
Mas ciencia, menos drama. The 2023 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
@CNN
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
RT @MenopauseJrnl: NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https:…
NAMS Position Statement: The 2023 #nonhormone #therapy position statement of The North American Menopause Society https://t.co/03h10TU7qk @MenopauseOrg @LippincottMed #menopause
The 2023 nonhormone therapy position statement of The North American Menopause Society https://t.co/f90rCvxvN5
10.1097/GME.0000000000002200 © 2023 by The North American Menopause Society 1 Hardy C, Griffiths A, Norton S, Hunter MS. „Self-help 3 cognitive behavior ...
Menopause 2023;30:573-90. 10.1097/GME.0000000000002200. The Fawcett Society. Menopause and the workplace; 2022. Available from: https://www.fawcettsociety ...
doi: 10.1097/GME.0000000000002200. PMID: 37252752 11. Effriyanti, R.Y. ... Menopause. 2015;22(5):489–95. 10.1097/GME.0000000000000363 22. Yoshitaka R ...
2023; doi:10.1097/GME.0000000000002200. Crandall CJ, et al. Management of menopausal symptoms: A review. JAMA. 2023; doi:10.1001/jama.2022.24140. Medical ...
doi:10.1097/GME.0000000000002200 [PubMed 37252752] - Page 92 of 112 - Escitalopram: Drug information. 192. Ogle NR, Akkerman SR. Guidance for the ...
2023;30(6):573-590. doi:10.1097/GME.0000000000002200[PubMed 37252752]. Naseri K, Saadati S, Sadeghi A, et al. The e"cacy of ginseng (Panax) on. human ...
2023; doi:10.1097/GME.0000000000002200. Crandall CJ, et al. Management of menopausal symptoms: A review. JAMA. 2023; doi:10.1001/jama.2022.24140. Medical ...
doi: 10.1097/gme.0000000000002200 16. Craig MC, Fletcher PC, Daly EM, Rymer J, Cutter WJ, Bram- 2. Maki PM, Jaff NG. Brain fog in menopause: a health-care ...
doi:10.1097/GME.0000000000000238. National Institute of Health: Office ... doi:10.1097/GME.0000000000002200. Akabas SR, Vannice G, Atwater JB, Cooperman ...
Menopause 2023;30:573-90. https://doi.org/10.3109/13697137.2015.1129166 https://doi.org/10.1097/GME.0000000000002200 5. Bateson D, McNamee K. Perimenopausal ...
doi:10.1097/GME.0000000000002200 2. Mann E, Smith MJ, Hellier J, et al: Cognitive behavioural treatment for women who have menopausal symptoms after breast ...
https://doi.org/10.1097/GME.0000000000002200. dose estradiol and norethisterone acetate: bleeding patterns and other outcomes [89] Heyerick A, Vervarcke S ...
Menopause 2023;30:573–90. Korpak AM, et al. Comparative venous thromboembolic safety doi: 10.1097/GME.0000000000002200 of oral and transdermal ...
doi:10.1097/GME. 0000000000002200. Hamoda H, Panay N, Arya R, Savvas M; BMS & Women's Health Concern 2020 recommendations on HRT in menopausal women. Post ...
Menopause: The Journal of The North American Menopause Society. Vol. 30, No. 6, pp. 573-590. DOI: 10.1097/GME.0000000000002200 © 2023 by The North American ...
2023; doi:10.1097/GME.0000000000002200. Crandall CJ, et al. Management of menopausal symptoms: A review. JAMA. 2023; doi:10.1001/jama.2022.24140. Medical ...
59 likes, 5 comments - filipe.psi on November 14, 2025: "Mulher, você sabia do uso da hipnose para reduzir suas ondas de calor durante a ...
cemech.ammef on October 18, 2025: "¡Hoy, 18 de octubre, conmemoramos el Día Mundial de la Menopausia! ✨ La menopausia es una etapa natural ...
... 10.1097/GME.0000000000002200. Hamoda H, Panay N, Arya R, Savvas M; BMS & Women's Health Concern 2020 recommendations on HRT in menopausal ...
176 likes, 4 comments - filipe.psi on September 13, 2025: "Registros de uma realização Oficialmente eu estou no site do Neuroscience ...
doi:10.1097/GME. 0000000000002200. Hamoda H, Panay N, Arya R, Savvas M; BMS & Women's Health Concern 2020 recommendations on HRT in ...
| DOI: 10.1097/GME.0000000000002200 Ranchordas MK, Rogerson D, Soltani H, Costello JT. Antioxidants for preventing and reducing muscle ...
100mg progesterone mono therapy for my early peri-menopause ladies that are mostly complaining of sleep and irritability. Then add E2 as symptoms progress.
2023; doi:10.1097/GME.0000000000002200. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022 ...
2023; doi:10.1097/GME.0000000000002200. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022 ...
doi:10.1097/GME. 0000000000002200. Hamoda H, Panay N, Arya R, Savvas M; BMS & Women's Health Concern 2020 recommendations on HRT in ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
2023; doi:10.1097/GME.0000000000002200. FAQs: The menopause years. American College of Obstetricians and Gynecologists. https://www.acog.org ...
doi: 10.1097/GME.0000000000002200. PMID: 37252752. Like · Reply · 1 Reaction 2 Reactions. See more comments. To view or add a comment, sign in ...
2023;doi:10.1097/GME.0000000000002200. Truong SR, et al. J Gynecol Obstet. 2019;doi:10.11648/j.jgo.20190702.11. For more information: Leslie ...
Menopause. 2023;doi:10.1097/GME.0000000000002200. Tessier J, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.19926 ...
Menopause. 2023;doi:10.1097/GME.0000000000002200. Truong SR, et al. J Gynecol Obstet. 2019;doi:10.11648/j.jgo ...
DOI: 10.1097/GME.0000000000002200. Journal information: Menopause. Copyright © 2023 HealthDay. All rights reserved. + Explore further. NAMS ...
2023;doi:10.1097/GME.0000000000002200. “Many women cannot or prefer not to take hormone therapy for hot flashes, but they are often unsure ...
To learn more about NAMS, visit www.menopause.org. Journal. Menopause. DOI. 10.1097/GME.0000000000002200. Method of Research. Literature review ...
... 10.1097/GME.0000000000002200 © 2023 by The North American Menopause Society Abstract Objective: To update the evidence-based Nonhormonal ...
MM
MJ
BS
TS
TP
MV
AC
MC
MM
SG
MP
RV
MH
AT
RR
MD
A
HP